You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HIV-1/2 uninfected

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial (763SIP8/MPLA-5 vaccine)

Not yet recruiting
  • Healthy
  • 763SIP8/MPLA-5 vaccine
  • (no location specified)
Mar 15, 2023

HIV/AIDS Trial in Orlando, Boston, Houston (PGT121 + VRC07-523LS, PGT121 + VRC07-523LS + PGDM1400)

Completed
  • HIV/AIDS
  • PGT121 + VRC07-523LS
  • PGT121 + VRC07-523LS + PGDM1400
  • Orlando, Florida
  • +2 more
May 6, 2022

Healthy Trial in Rwanda, United States (Ad26.Mos.HIV, Ad26.Mos4.HIV, Clade C gp140)

Completed
  • Healthy
  • Ad26.Mos.HIV
  • +3 more
  • Birmingham, Alabama
  • +9 more
Jul 5, 2022

HIV Trial in Baltimore (ALVAC-HIV gp160MN (vCP125), ALVAC-RG Rabies Glycoprotein (vCP65), rgp120/HIV-1 SF-2)

Completed
  • HIV Infections
  • ALVAC-HIV gp160MN (vCP125)
  • +2 more
  • Baltimore, Maryland
    JHU AVEG
Oct 27, 2021

HIV Trial in Birmingham, Saint Louis, Rochester (ALVAC-HIV MN120TMG (vCP205), ALVAC-RG Rabies Glycoprotein (vCP65), rgp120/HIV-1

Completed
  • HIV Infections
  • ALVAC-HIV MN120TMG (vCP205)
  • +2 more
  • Birmingham, Alabama
  • +2 more
Oct 28, 2021

HIV Trial in United States (MF59, rgp120/HIV-1 SF-2)

Completed
  • HIV Infections
  • MF59
  • rgp120/HIV-1 SF-2
  • Birmingham, Alabama
  • +3 more
Oct 27, 2021

HIV Trial in United States (ALVAC-HIV MN120TMGNP (vCP300), ALVAC-RG Rabies Glycoprotein (vCP65), rgp120/HIV-1 SF-2)

Completed
  • HIV Infections
  • ALVAC-HIV MN120TMGNP (vCP300)
  • +2 more
  • Birmingham, Alabama
  • +5 more
Oct 28, 2021

HIV Trial in United States (ALVAC-HIV MN120TMG (vCP205), ALVAC-RG Rabies Glycoprotein (vCP65), rgp120/HIV-1 SF-2)

Completed
  • HIV Infections
  • ALVAC-HIV MN120TMG (vCP205)
  • +2 more
  • Birmingham, Alabama
  • +5 more
Oct 27, 2021

HIV Trial (1% tenofovir gel, Placebo gel)

Withdrawn
  • HIV Infections
  • 1% tenofovir gel
  • Placebo gel
  • (no location specified)
Oct 28, 2021

HIV Trial in Birmingham, San Francisco, Seattle (pGA2/JS2 Plasmid DNA Vaccine)

Completed
  • HIV Infections
  • pGA2/JS2 Plasmid DNA Vaccine
  • Birmingham, Alabama
  • +3 more
Oct 13, 2021

HIV Trial in Saint Louis, Rochester, Seattle (Aluminum hydroxide, Lipid A, Monophosphoryl, Lipid A, Liposome-encapsulated

Completed
  • HIV Infections
  • Aluminum hydroxide
  • +7 more
  • Saint Louis, Missouri
  • +2 more
Oct 28, 2021

HIV Trial in United States (ALVAC-HIV MN120TMG (vCP205), ALVAC-RG Rabies Glycoprotein (vCP65), rgp120/HIV-1 SF-2)

Completed
  • HIV Infections
  • ALVAC-HIV MN120TMG (vCP205)
  • +2 more
  • Birmingham, Alabama
  • +5 more
Oct 28, 2021

HIV Trial in United States (MN rgp120/HIV-1 and GNE8 rgp120/HIV-1, MN rgp120/HIV-1 and A244 rgp120/HIV-1, ALVAC-HIV MN120TMG

Completed
  • HIV Infections
  • MN rgp120/HIV-1 and GNE8 rgp120/HIV-1
  • +3 more
  • Birmingham, Alabama
  • +17 more
Oct 27, 2021

HIV Trial in Bronx (Tenofovir gel, Tenofovir gel )

Completed
  • HIV Infections
  • Tenofovir gel
  • Tenofovir gel placebo
  • Bronx, New York
    Albert Einstein College of Medicine - East Campus GCRC (Herold)
Oct 28, 2021

HIV Trial in United States (VRC-HIVDNA009-00-VP)

Completed
  • HIV Infections
  • VRC-HIVDNA009-00-VP
  • Birmingham, Alabama
  • +13 more
Oct 13, 2021

HIV Trial in Boston, Johannesburg, Cape Town (Sub C gp140 Vaccine, MF59C.1 Adjuvant, Sodium chloride)

Completed
  • HIV Infections
  • Sub C gp140 Vaccine
  • +2 more
  • Boston, Massachusetts
  • +3 more
Oct 13, 2021

HIV Trial in Worldwide (ALVAC-HIV (vCP2438), Bivalent subtype C gp120/MF59, Bivalent subtype C gp120/AS01(B))

Completed
Has Results
  • HIV Infections
  • ALVAC-HIV (vCP2438)
  • +3 more
  • San Francisco, California
  • +11 more
Oct 6, 2021

COVID-19 Trial in South Africa (Ad26.COV2.S (VAC31518, JNJ-78436735) Vaccine, SARS-CoV-2 rS (CovovaxTM), BNT162b2 (Pfizer))

Recruiting
  • COVID-19
  • Ad26.COV2.S (VAC31518, JNJ-78436735) Vaccine, SARS-CoV-2 rS (CovovaxTM), BNT162b2 (Pfizer)
  • Pretoria, Gauteng, South Africa
  • +4 more
Aug 23, 2022

HIV, HIV Seronegativity Trial in United States (ALVAC(2)120(B,MN)GNP (vCP1452))

Completed
  • HIV Infections
  • HIV Seronegativity
  • ALVAC(2)120(B,MN)GNP (vCP1452)
  • Birmingham, Alabama
  • +12 more
Oct 13, 2021

HIV Trial in Mozambique, South Africa, Zimbabwe (ALVAC-HIV (vCP2438), Bivalent Subtype C gp120/MF59, Bivalent Subtype C gp120

Completed
Has Results
  • HIV Infections
  • ALVAC-HIV (vCP2438)
  • +3 more
  • Maputo, Mozambique
  • +5 more
Nov 18, 2021

HIV Infection Trial in South Africa (ALVAC-HIV, Bivalent Subtype C gp120/MF59®, ALVAC-HIV (vCP2438) Placebo)

Completed
Has Results
  • HIV Infection
  • ALVAC-HIV
  • +3 more
  • Durban, KwaZulu-Natal, South Africa
  • +4 more
Nov 3, 2021

HIV Trial in United States (ALVAC(2)120(B,MN)GNP (vCP1452), gp160 MN/LAI-2, ALVAC(1)120(B,MN)GNP (vCP1433))

Completed
  • HIV Infections
  • ALVAC(2)120(B,MN)GNP (vCP1452)
  • +4 more
  • Birmingham, Alabama
  • +5 more
Oct 27, 2021

HIV Trial in United States (VRC-HIVDNA009-00-VP (Gag-Pol-Nef-multiclade-Env) with adjuvant VRC-ADJDNA004-IL2-VP)

Completed
  • HIV Infections
  • VRC-HIVDNA009-00-VP (Gag-Pol-Nef-multiclade-Env) with adjuvant VRC-ADJDNA004-IL2-VP
  • Baltimore, Maryland
  • +6 more
Oct 13, 2021

HIV Trial in United States (PGT121.414.LS, VRC07-523LS)

Completed
  • HIV Infections
  • PGT121.414.LS
  • VRC07-523LS
  • Los Angeles, California
  • +4 more
Jan 31, 2023

Healthy Adults Trial (Drep-HIV-PT1 0.2mg and CN54gp140/MPLA-L, DREP-HIV-PT1 1mg and CN54gp140/MPLA-L (see above), DNA-HIV-PT123

Not yet recruiting
  • Healthy Adults
  • Drep-HIV-PT1 0.2mg and CN54gp140/MPLA-L
  • +2 more
  • (no location specified)
Apr 9, 2021